SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-329394
Filing Date
2017-11-01
Accepted
2017-11-01 16:07:06
Documents
59
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d462763d10q.htm 10-Q 620805
2 EX-31.1 d462763dex311.htm EX-31.1 6668
3 EX-31.2 d462763dex312.htm EX-31.2 6484
4 EX-32.1 d462763dex321.htm EX-32.1 3813
11 GRAPHIC g462763g1031033132043.jpg GRAPHIC 62776
12 GRAPHIC g462763g1031033132308.jpg GRAPHIC 39361
  Complete submission text file 0001193125-17-329394.txt   3298936

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20170930.xml EX-101.INS 548546
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20170930.xsd EX-101.SCH 36937
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20170930_cal.xml EX-101.CAL 51802
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20170930_def.xml EX-101.DEF 108733
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20170930_lab.xml EX-101.LAB 308318
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20170930_pre.xml EX-101.PRE 213664
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 171168989
SIC: 2834 Pharmaceutical Preparations